Nestlé to Sell Palforzia Peanut Allergy Treatment

XTalks

Food giant Nestlé put its Palforzia peanut allergy treatment up for sale only two years after acquiring the company that developed it for $2.6 The drug may alleviate some of the symptoms associated with the allergy such as constriction of airways, hives and swelling.

Top 3 Allergy Friendly Food Brands

XTalks

According to the Asthma and Allergy Foundation of America, about 32 million people in the US have food allergies, which means allergy friendly food brands not only have a large audience base, but are also necessities.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Pfizer's Covid Vaccine and Allergies: How Concerned Should You Be?

NY Times

British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.

How the food allergy sector is benefitting from health tech’s recent boom

Pharma Phorum

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. per person being spent on food allergy research. The rise of food allergy platforms.

Peanut Allergy Market Outlook: The Market Size Growth Sees Major Thrusts

Delveinsight

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. However, in 2017 the treatment paradigm in the Peanut allergy therapy market transformed to incorporate different treatment approaches and pharmacotherapies.

Are milk allergies over-diagnosed in infants?

Scienmag

In an analysis of data on 1,303 healthy infants who were exclusively breastfed until at least 3 months of age, 38% and 74% of infants had multiple mild-to-moderate milk allergy symptoms—as defined by current allergy guidelines—at 3 months and 12 months old, respectively. The findings, which are published in Clinical & Experimental Allergy, suggest that […]. Latest News allergies infants milk overdiagnosed

Allergy Treatment Market Report 2021: Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies); Treatment (Anti-Allergy Drugs, and Immunotherapy) – ResearchAndMarkets.com

BioTech 365

Allergy Treatment Market Report 2021: Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies); Treatment (Anti-Allergy Drugs, and Immunotherapy) – ResearchAndMarkets.com Allergy Treatment Market Report 2021: Analysis By Allergy Type (Eye Allergy, Rhinitis, Asthma, … Continue reading → Business Wire

Tackling food allergies at the source

Scienmag

Credit: Eliot Herman Food allergies are a big problem. suffer from some kind of food allergy. These allergies cost a whopping $25 billion in health care each year. About 7% of children and 2% of adults in the U.S.

Genetic and molecular insights into dangerous tick bite-related meat allergy revealed

Scienmag

Scientists have revealed the genetic and molecular structure of key molecules linked to the sometimes life-threatening mammalian-meat allergy brought on by tick bites. Chemistry AND Physics allergy biterelated dangerous genetic insights meat molecular revealed tick

Yes, allergy seasons are getting worse; blame climate change

Scienmag

Credit: William Anderegg If you live with seasonal allergies and feel like the pollen seasons feel longer and longer every year, you may be right. Agriculture Biology Climate Change Ecology/Environment Immunology/Allergies/Asthma Plant Sciences

NICE backs Aimmune’s peanut allergy drug Palforzia for children

Pharma Phorum

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England.

Researchers lay groundwork for potential dog-allergy vaccine

Scienmag

There have been many research efforts describing the nature and progression of dog allergies, but there have been very few applied studies that use this information to try to cure people of dog allergies entirely by artificially inducing immune tolerance.

What People With Allergies Should Know About Covid Vaccines

NY Times

Clinical Trials Allergies Vaccination and Immunization Drugs (Pharmaceuticals) Asthma Immune System Coronavirus (2019-nCoV) your-feed-healthcareFour people so far have had allergic reactions after getting the Pfizer-BioNTech vaccine.

Oral immunotherapy induces remission of peanut allergy in some young children

Scienmag

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.

John Walter Named CEO of Food Allergy Science Initiative

BioTech 365

John Walter Named CEO of Food Allergy Science Initiative John Walter Named CEO of Food Allergy Science Initiative Dr. Christine Olsen transitions to executive chair of the organization’s board of directors CAMBRIDGE, Mass.–(BUSINESS

Can you use montelukast for allergies? [ANSWERED]

Druggist

Today I will explore a different use of montelukast and answer the main question: can you use montelukast for allergies? Can you use montelukast for allergies? Can you use montelukast for allergies? Use of montelukast for allergies: what is the evidence? .

Nestlé buys the rest of Aimmune, aiming to boost a struggling peanut allergy treatment

Bio Pharma Dive

The Swiss firm will take over the launch of Aimmune's Palforzia, sales of which have disappointed since its approval in January

Worldwide Allergy Immunotherapies Industry to 2027 – Featuring Allergy Therapeutics, DBV Technologies and Anergis Among Others – ResearchAndMarkets.com

BioTech 365

Worldwide Allergy Immunotherapies Industry to 2027 – Featuring Allergy Therapeutics, DBV Technologies and Anergis Among Others – ResearchAndMarkets.com Worldwide Allergy Immunotherapies Industry to 2027 – Featuring Allergy Therapeutics, DBV Technologies and Anergis Among Others – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Allergy Immunotherapies … Continue reading → Business Wire

8 Of The Most Common Foods Allergies – Do You Have One?

Delveinsight

As per the Food Allergy Research & Education, in the US, each year, around 200,000 people require emergency medical care for allergic reactions to food. Food allergy is a specific immune response to certain food items that it considers harmful. Egg Allergy. Milk Allergy.

Infant antibiotic exposure can affect future immune responses toward allergies

Scienmag

Medicine & Health Immunology/Allergies/Asthma Medicine/Health PediatricsEarly life exposure to antibotics in utero and through mother’s milk disrupts beneficial gut bacteria, compromising T-cell development, Rutgers research shows Exposure to antibiotics in utero and infancy can lead to an irreversible loss of regulatory T-cells in the colon-a valuable component of the immune system’s response toward allergens in later life – after only […].

Food allergies, changes to infant gut bacteria linked to method of childbirth, ethnicity

Scienmag

Medicine & Health Developmental/Reproductive Biology Gastroenterology Gynecology Immunology/Allergies/Asthma Internal Medicine Medicine/Health

Angany Partners with Mass General on Potential Peanut Allergy Vaccine

BioSpace

Angany entered into collaboration for a series of preclinical studies that will evaluate the safety and efficacy of BP/AH-01, Angany’s lead peanut allergy biological candidate

FDA approves IND application for peanut allergy drug candidate

Outsourcing Pharma

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.

Gene variants help explain connection between skin disorder and food allergy risk

Scienmag

Medicine & Health Dermatology Genetics Immunology/Allergies/Asthma Medicine/Health Pediatrics

Coronavirus vaccine may have allergy warning in US, says expert

Pharma Phorum

Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Elastic-free face masks can help some with allergies stay safe during COVID-19

Scienmag

Medicine & Health Dermatology Immunology/Allergies/Asthma Infectious/Emerging Diseases Internal Medicine Medicine/Health Public Health

Nestlé to acquire Aimmune Therapeutics, growing food allergy portfolio

BioPharma Reporter

Swiss giant Nestlà is to acquire Aimmune Therapeutics, a biopharmaceutical company developing and commercializing treatments for food allergies. Aimmuneâs Palforzia is the worldâs first approved treatment for peanut allergy.

Avoid Allergy Flare-Ups This Holiday Season

The Pharma Data

Avoid Allergy Flare-Ups This Holiday Season. But indoor allergies could also take the joy out of your holiday season, an expert says. Dust, mold, pets, furniture and houseplants can cause indoor allergies, said Dr. David Corry. Consumer News.

IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies

BioTech 365

IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies SOUTH SAN FRANCISCO, Calif.–(BUSINESS

Global Ragweed Pollen Hypersensitivity Pipeline Research Report 2021 Featuring HAL Allergy, ASIT Biotech, Allergy Therapeutics, & Anergis – ResearchAndMarkets.com

BioTech 365

Global Ragweed Pollen Hypersensitivity Pipeline Research Report 2021 Featuring HAL Allergy, ASIT Biotech, Allergy Therapeutics, & Anergis – ResearchAndMarkets.com Global Ragweed Pollen Hypersensitivity Pipeline Research Report 2021 Featuring HAL Allergy, ASIT Biotech, Allergy Therapeutics, & Anergis – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading → Business Wire

Allergy specialist Stallergenes taps Aptar for digital delivery

Pharma Phorum

AIT involves the administration of controlled, low doses of allergens under the tongue or by subcutaneous injection in people with allergies, with the aim of desensitising the immune system to them and prevent allergic reactions.

With or without allergies, outcomes similar for hospitalized patients with COVID-19

Scienmag

Study shows similar rates of ICU admission and severity of disease Credit: ACAAI ARLINGTON HEIGHTS, Ill (November 13, 2020) – During the COVID-19 pandemic, attention has been focused on how those with both allergies and asthma might be affected should they become ill.

Allergy season starts earlier each year due to climate change and pollen transport

Scienmag

Scientists in Munich study how pollen from far distances — sometimes hundreds of kilometers away — affects the length of allergy seasons in Germany Credit: A. Yuan, Technical University of Munich Allergy sufferers are no strangers to problems with pollen.

LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform

BioTech 365

LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform Acquisition of Cleared Further Diversifies LifeMD’s Telehealth Offerings to Encompass Allergy, Asthma, and Immunology Acquisition Expected to Synergize with LifeMD Virtual … Continue reading → GlobeNewswire

Study shows psychosocial effects of peanut allergy

Pharma Times

Research demonstrates that people who live with peanut allergies face isolation and discrimination

ALK spotlights the impact of respiratory allergies on children at EAACI Congress

BioTech 365

ALK spotlights the impact of respiratory allergies on children at EAACI Congress ALK spotlights the impact of respiratory allergies on children at EAACI Congress Four leading experts in respiratory allergy spotlight the impact of respiratory allergy in children, in an … Continue reading → GlobeNewswire

Ready, Set, Food! Receives $3.5 Million to Help Parents Fight the Food Allergy Epidemic

XTalks

who is on a mission to help parents save their children from food allergies by providing them with a powder added to their milk bottles. Zakowski started this company because his nephew developed several severe food allergies. Related: Red Meat Allergy Test Gets FDA Clearance.

Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com

BioTech 365

Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com Global Peanut Allergy Clinical Trials Review, H2 2021 Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Peanut Allergy – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s … Continue reading → Business Wire

New patent for Bayer Hlthcare drug ASTEPRO ALLERGY

Drug Patent Watch

Annual Drug Patent Expirations for ASTEPRO+ALLERGY Astepro Allergy is a drug marketed by Bayer Hlthcare and is included in one NDA. The generic ingredient in ASTEPRO ALLERGY is azelastine hydrochloride.….

Moms need guidance on what to eat when their breastfeeding infant has a food allergy

Scienmag

Medicine & Health Immunology/Allergies/Asthma Medicine/Health PediatricsStudy shows 30% of moms got conflicting advice on eating the same food their infant is allergic to ARLINGTON HEIGHTS, IL (March 4, 2021) – Many new mothers with infants want very much to breastfeed as it is the gold standard for early nutrition. What to do when you find out your young child has […].

New patent for Bayer Hlthcare drug ASTEPRO ALLERGY

Drug Patent Watch

Annual Drug Patent Expirations for ASTEPRO+ALLERGY Astepro Allergy is a drug marketed by Bayer Hlthcare and is included in one NDA. The generic ingredient in ASTEPRO ALLERGY is azelastine hydrochloride.….

FDA rejects a peanut allergy treatment, sinking a small biotech's shares

Bio Pharma Dive

Given the long list of requirements in the FDA's rejection letter, DBV Technologies likely has years of work ahead to win approval of Viaskin Peanut

Best’s Commentary: Thailand Insurers Offer Innovative Vaccine Allergy Product, But Underwriting Risks Remain

BioTech 365